Cargando…

Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days

BACKGROUND: A vaccine against coronavirus disease 2019 (COVID-19) with highly effective protection is urgently needed. The anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and duration after vaccination are crucial predictive indicators. OBJECTIVES: To evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qiu-Yan, Xue, Jian-Hang, Xiao, Yao, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Li, Wei-Li, Liang, Xian-Ming, Yang, Tian-Ci
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733590/ https://www.ncbi.nlm.nih.gov/pubmed/35003104 http://dx.doi.org/10.3389/fimmu.2021.786554

Ejemplares similares

A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study at 18 Serial Time Points Over 368 Days
por: Liang, Xian-Ming, et al.
Publicado: (2022)

Evaluation of the efficacy of four anti-SARS-CoV-2 antibodies after vaccination using kits from two manufacturers: A prospective, longitudinal, cohort study at 11 serial time points within 160 days
por: Xie, Lin, et al.
Publicado: (2022)

High Levels of CD244 Rather Than CD160 Associate With CD8(+) T-Cell Aging
por: Wang, Xinyue, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)

The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study
por: Ou, Shanhai, et al.
Publicado: (2022)

CD160 receptor in CLL: Current state and future avenues
por: Oumeslakht, Loubna, et al.
Publicado: (2022)

Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
por: Wen, Gui-Ping, et al.
Publicado: (2023)

HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage
por: Muscate, Franziska, et al.
Publicado: (2018)

Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines
por: Li, Ping, et al.
Publicado: (2022)

Clinical profiles and risk factors of 7-day and 30-day mortality among 160 pediatric patients with hemophagocytic lymphohistiocytosis
por: Li, Xun, et al.
Publicado: (2020)

CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells
por: Zhang, Linxia, et al.
Publicado: (2020)

Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study
por: Li, Hong-Yan, et al.
Publicado: (2022)

CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression
por: Sun, Zheng, et al.
Publicado: (2022)

Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays
por: Zheng, Peiyan, et al.
Publicado: (2023)

The Outer Membrane Lipoprotein Tp0136 Stimulates Human Platelet Activation and Aggregation Through PAR1 to Enhance G(q)/G(i) Signaling
por: Xu, Qiu-Yan, et al.
Publicado: (2022)

Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study
por: Xu, Nani, et al.
Publicado: (2023)

Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction
por: Li, Hu, et al.
Publicado: (2023)

Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
por: Zhu, Hong-Hong, et al.
Publicado: (2023)

Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy
por: Xie, Jiayong, et al.
Publicado: (2021)

Neutralizing Antibody Response in Dogs and Cats Inoculated with Commercial Inactivated Rabies Vaccines
por: SHIRAISHI, Rikiya, et al.
Publicado: (2013)

Duration biased distribution of clinical and immunological phenotypes in active SLE
por: Yan, Qingran, et al.
Publicado: (2022)

Electron-Beam Inactivation of Human Rotavirus (HRV) for the Production of Neutralizing Egg Yolk Antibodies
por: Skrobarczyk, Jill W., et al.
Publicado: (2022)

Anti-SARS-CoV-2 IgM Secondary Response Was Suppressed by Preexisting Immunity in Vaccinees: A Prospective, Longitudinal Cohort Study over 456 Days
por: Xu, Qiu-Yan, et al.
Publicado: (2023)

Serum albumin binding knob domains engineered within a V(H) framework III bispecific antibody format and as chimeric peptides
por: Adams, Ralph, et al.
Publicado: (2023)

BBBBB160 /
por: Kozer, José
Publicado: (2013)

Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective study
por: Fang, Xiqin, et al.
Publicado: (2022)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
por: Wang, Jin, et al.
Publicado: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old
por: Medeiros, Giuliana X., et al.
Publicado: (2022)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Zhao, Xiaobin, et al.
Publicado: (2021)

160. Evaluation of an Intervention to Promote Guideline-Concordant Durations of Antibiotic Therapy in Two Urgent Care Centers
por: Shihadeh, Katherine C, et al.
Publicado: (2021)

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine
por: Yao, Yufeng, et al.
Publicado: (2019)

Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children
por: Li, Jia-Nan, et al.
Publicado: (2023)

Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination
por: Wang, Fuzhen, et al.
Publicado: (2022)

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis
por: Cao, Huanhuan, et al.
Publicado: (2023)

Impact of inactivated COVID-19 vaccination on female ovarian reserve: a propensity score-matched retrospective cohort study
por: Huang, Jialyu, et al.
Publicado: (2023)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS‐CoV‐2
por: Hu, Xiumei, et al.
Publicado: (2020)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uc4f6v2ktnfen26f8iiplp4ek3